The size of the Asia Pacific Burn Care Market has been forecasted at USD 0.41 billion in 2022. It is further estimated to grow and worth USD 0.58 billion by the end of 2027, hiking at a CAGR of 7.4% from 2022 to 2027.
Burn care is a major challenge in Asia, having the highest female mortality globally due to flame burns. Burns are more frequent in the rural region, affecting the poor. The most common causes are kerosene and flammable flowing garments worn by women. Burn injuries cause sickness and mortality globally. Despite taking preventative measures, there are still many cases reported in countries such as India, China. The treatment for the patients is often protracted and requires extensive resources.
Children get injured due to floor level storing of hot liquids such as food items, milk, and water. Farmers get many electrical burns during the agriculture phase since they get electricity directly from the mainline to pump water to the farm. Kerosene is a highly flammable liquid available in every household in India and is used in most intentional injuries. In India, over 1,000,000 people are moderately or severely burnt every year. In Tokyo, burn injuries are a severe problem; approximately 1250 were burned severely.
The Major factors that contribute to the market's growth are the rising incidence of burns due to lack of education to vulnerable populations, growing expenditure in Healthcare due to increased usage of skin grafts, and favorable government initiatives resulting in an increasing number of emergency burn units and clinics.
These Biologics are predicted to account for India's largest share, and advanced dressings are expected to account for the highest share in japan. Among these, Hospitals are expected to account for the largest share in the market.
This research report on the Asia Pacific Burn Care Market has been segmented and sub-segmented into the following categories:
By Extent of Damage:
Some of the promising companies leading the Asia Pacific Burn Care Market Profiled in the Report are Smith & Nephew plc (U.K.), Acelity L.P (U.S.), 3M Company (U.S.), Molnlycke Health Care (Sweden), Derma Sciences Inc. (U.S.), Medtronic (Ireland), Coloplast A/S (Denmark) and Convatec Inc (U.K.).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org